For patients diagnosed with SHPT, invasive treatments are recommended if they exhibit symptoms or meet criteria such as persistent elevation in serum PTH levels, hypercalcaemia or hyperphosphataemia with inadequate medication response. Here, PTH is linked to hyperphosphatemia.